Cargando…
Assessment of neuroprotection in the retina with DARC
Currently, assessment of new drug efficacy in glaucoma relies on conventional perimetry to monitor visual field changes. However, visual field defects cannot be detected until 20–40% of retinal ganglion cells (RGCs), the key cells implicated in the development of irreversible blindness in glaucoma,...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2603274/ https://www.ncbi.nlm.nih.gov/pubmed/18929126 http://dx.doi.org/10.1016/S0079-6123(08)01130-8 |